Stockscreener 앱 받기
0.38%
시간 외 거래:
Amgen Inc 주식(AMGN)의 최신 뉴스
Amgen Inc. (NASDAQ:AMGN) Stock Position Lowered by Morningstar Investment Services LLC - MarketBeat
SNS Financial Group LLC Decreases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Private Advisor Group LLC Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Lobbying Update: $2,580,000 of AMGEN INC lobbying was just disclosed - Quiver Quantitative
Amgen’s Promising Study on Advanced Gastric Cancer: What Investors Need to Know - TipRanks
Amgen’s Jyothis George named NodThera CMO - The Pharma Letter
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Arrow Financial Corp - MarketBeat
Humira Biosimilar Market Gains Momentum Post-Patent Expiry & - openPR.com
Peregrine Asset Advisers Inc. Reduces Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
J.W. Cole Advisors Inc. Has $3.60 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer - GlobeNewswire Inc.
Larson Financial Group LLC Boosts Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
What drives Amgen Inc. stock priceUnprecedented market success - Autocar Professional
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Forum Financial Management LP - MarketBeat
Amgen Stock (AMGN) Opinions on Recent Price Declines and Technical Trends - Quiver Quantitative
Los Angeles Capital Management LLC Increases Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Wealth Alliance LLC Acquires 999 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Souders Financial Advisors Sells 4,633 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Heritage Investors Management Corp Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Teachers Retirement System of The State of Kentucky Acquires 1,839 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Twin Capital Management Inc. Has $6.24 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Position Raised by OneAscent Financial Services LLC - MarketBeat
Elyxium Wealth LLC Invests $618,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Copperwynd Financial LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Rep. Cliff Bentz Purchases Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cullen Frost Bankers Inc. Purchases 4,162 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Evergreen Wealth Management LLC Has $2.64 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
What analysts say about Amgen Inc. stockConsistent double returns - jammulinksnews.com
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Commerzbank Aktiengesellschaft FI - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Verdence Capital Advisors LLC - MarketBeat
Parcion Private Wealth LLC Sells 1,188 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. Stock Analysis and ForecastPhenomenal wealth increase - Autocar Professional
Concord Wealth Partners Has $3.09 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Is Amgen Inc. a good long term investmentRapid market gains - jammulinksnews.com
Balentine LLC Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by St. Louis Trust Co - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Cut by Jennison Associates LLC - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Edgestream Partners L.P. - MarketBeat
Why Amgen (AMGN) Could Be a Hidden Gem Among Dividend Pharma Stocks in 2025 - Yahoo Finance
Amgen (AMGN) Declines More Than Market: Some Information for Investors - Yahoo Finance
Leo Wealth LLC Sells 1,746 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
HSBC Trims Amgen (AMGN) Price Target, Maintains Buy Rating - MSN
Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And More - Seeking Alpha
Amgen’s Phase 3 Study on Etelcalcetide: A Potential Game-Changer for Pediatric Kidney Disease - TipRanks
Amgen’s New Study on SCLC Treatment: A Potential Game Changer? - TipRanks
Amgen’s AMG 193 Study: A Potential Game-Changer in Thoracic Tumor Treatment - TipRanks
Amgen’s Romiplostim Study: A Potential Game-Changer for Chemotherapy Patients - TipRanks
Will Amgen Inc. stock benefit from interest rate changes2x 3x 5x Pick Alert - beatles.ru
Amgen’s Promising Phase 3 Study: Maridebart Cafraglutide for Obesity in Type 2 Diabetes - TipRanks
Amgen’s Avacopan Study: A Potential Game-Changer in Vasculitis Treatment - TipRanks
Amgen’s Promising Phase 3 Study on Metastatic Colorectal Cancer: A Potential Game-Changer - TipRanks
Amgen’s Promising Phase 3 Study on Dazodalibep for Sjögren’s Syndrome - TipRanks
Amgen’s Phase 2 Study on HZN-1116: A Potential Breakthrough for Sjögren’s Syndrome - TipRanks
Amgen and Novartis’s Erenumab Study: A Potential Game-Changer in Pediatric Migraine Treatment - TipRanks
Amgen’s ABP 234 vs. Keytruda®: A New Frontier in Lung Cancer Treatment? - TipRanks
0.86%
0.06%
자본화:
|
볼륨(24시간):